Drug used for another disease slows progression of Parkinson’s

8 octubre 2014

A drug being evaluated to treat an entirely different disorder helped slow the progression of Parkinson’s disease in mice, a team of researchers has reported. Their study found that the drug, AT2101, which has also been studied for Gaucher disease, improved motor function, stopped inflammation in the brain and reduced levels of alpha-synuclein, a protein critically involved in Parkinson’s.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/5sPepJHSG0Q/141008153507.htm

Volver